User menu

Unambiguous Detection of Multiple TP53 Gene Mutations in AAN-Associated Urothelial Cancer in Belgium Using Laser Capture Microdissection

Bibliographic reference Aydin, Selda ; Dekairelle, Anne-France ; Ambroise, Jérôme ; Durant, Jean-François ; Heusterspreute, Michel ; et. al. Unambiguous Detection of Multiple TP53 Gene Mutations in AAN-Associated Urothelial Cancer in Belgium Using Laser Capture Microdissection. In: PLoS One, Vol. 9, no.9, p. e106301 (2014)
Permanent URL http://hdl.handle.net/2078.1/150515
  1. Vanherweghem J-L., Tielemans C., Abramowicz D., Depierreux M., Vanhaelen-Fastre R., Vanhaelen M., Dratwa M., Richard C., Vandervelde D., Verbeelen D., Jadoul M., Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs, 10.1016/0140-6736(93)92984-2
  2. Vanhaelen Maurice, Vanhaelen-Fastre Renée, But Paul, Vanherweghem Jean-Louis, Identification of aristolochic acid in Chinese herbs, 10.1016/s0140-6736(94)90964-4
  3. Depierreux Michel, Van Damme Baudewijn, Vanden Houte Kaat, Vanherweghem Jean Louis, Pathologic Aspects of a Newly Described Nephropathy Related to the Prolonged Use of Chinese Herbs, 10.1016/s0272-6386(12)80178-8
  4. Cosyns Jean-Pierre, Jadoul Michel, Squifflet Jean-Paul, de Plaen Jean-François, Ferluga Dusan, Van Ypersele de Strihou Charles, Chinese herbs nephropathy: A clue to Balkan endemic nephropathy?, 10.1038/ki.1994.220
  5. Cosyns Jean-Pierre, Jadoul Michel, Squifflet Jean-Paul, Wese François-Xavier, van Ypersele de Strihou Charles, Urothelial lesions in Chinese-herb nephropathy, 10.1016/s0272-6386(99)70136-8
  6. Nortier Joëlle L., Martinez Marie-Carmen Muniz, Schmeiser Heinz H., Arlt Volker M., Bieler Christian A., Petein Michel, Depierreux Michel F., De Pauw Luc, Abramowicz Daniel, Vereerstraeten Pierre, Vanherweghem Jean-Louis, Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi), 10.1056/nejm200006083422301
  7. Grollman Arthur P., Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease, 10.1002/em.21756
  8. Schmeiser H.H., Scherf H.R., Wiessler M., Activating mutations at codon 61 of the c-Ha-ras gene in thin-tissue sections of tumors induced by aristolochic acid in rats and mice, 10.1016/0304-3835(91)90178-k
  9. Stiborová Marie, Fernando R. Charles, Schmeiser Heinz H., Frei Eva, Pafau Wolfgang, Wiessler Manfred, Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures, 10.1093/carcin/15.6.1187
  10. JP Cosyns, Drug Safety, 26, 33 (2003)
  11. Grollman A. P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., Suzuki N., Fernandes A., Rosenquist T., Medverec Z., Jakovina K., Brdar B., Slade N., Turesky R. J., Goodenough A. K., Rieger R., Vukelic M., Jelakovic B., Aristolochic acid and the etiology of endemic (Balkan) nephropathy, 10.1073/pnas.0701248104
  12. Moriya Masaaki, Slade Neda, Brdar Branko, Medverec Zvonimir, Tomic Karla, Jelaković Bojan, Wu Lin, Truong Sim, Fernandes Andrea, Grollman Arthur P., TP53 Mutational signature for aristolochic acid: an environmental carcinogen, 10.1002/ijc.26077
  13. Jelaković Bojan, Karanović Sandra, Vuković-Lela Ivana, Miller Frederick, Edwards Karen L., Nikolić Jovan, Tomić Karla, Slade Neda, Brdar Branko, Turesky Robert J., Stipančić Želimir, Dittrich Damir, Grollman Arthur P., Dickman Kathleen G., Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid, 10.1038/ki.2011.371
  14. Chen C.-H., Dickman K. G., Moriya M., Zavadil J., Sidorenko V. S., Edwards K. L., Gnatenko D. V., Wu L., Turesky R. J., Wu X.-R., Pu Y.-S., Grollman A. P., Aristolochic acid-associated urothelial cancer in Taiwan, 10.1073/pnas.1119920109
  15. HH Schmeiser, Cancer Res, 56, 2025 (1996)
  16. Bieler C., 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy, 10.1093/carcin/18.5.1063
  17. Hermans M. P., Gala J.-L., Buysschaert M., The MTHFR C677T polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes, 10.1111/j.1464-5491.2006.01841.x
  18. Arlt Volker M, Pfohl-Leszkowicz Annie, Cosyns Jean-Pierre, Schmeiser Heinz H, Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy, 10.1016/s1383-5718(01)00188-7
  19. Gökmen M. Refik, Cosyns Jean-Pierre, Arlt Volker M., Stiborová Marie, Phillips David H., Schmeiser Heinz H., Simmonds Monique S.J., Cook H. Terence, Vanherweghem Jean-Louis, Nortier Joëlle L., Lord Graham M., The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy : A Narrative Review, 10.7326/0003-4819-158-6-201303190-00006
  20. Kanaan N., The importance of a histology-based diagnosis of interstitial nephropathy in two patients with renal insufficiency, 10.1093/ndt/18.2.440
  21. Sauter G, Algaba F, Amin MB, Busch C, Cheville J, et al.. (2004) Non-invasive urothelial tumours. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. World Health Organization classification of tumours:pathology and genetics of tumours of the urinary system and male genital organs. Lyon, France: IARC Press. pp. 110–123.
  22. Hodges Kurt B., Lopez-Beltran Antonio, Davidson Darrell D., Montironi Rodolfo, Cheng Liang, Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features, 10.1016/j.humpath.2009.07.002
  23. JP Gao, Int J Oncol, 16, 469 (2000)
  24. Olivier M., Hollstein M., Hainaut P., TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use, 10.1101/cshperspect.a001008
  25. Dekairelle A.-F., Assessment of the Transcriptional Activity of p53 Improves the Prediction of Recurrence in Superficial Transitional Cell Carcinoma of the Bladder, 10.1158/1078-0432.ccr-05-0140
  26. Petersen Iver, Ohgaki Hiroko, Ludeke Barbara I., Kleihues Paul, p53 mutations in phenacetin-associated human urothelial carcinomas, 10.1093/carcin/14.10.2119
  27. Petitjean Audrey, Mathe Ewy, Kato Shunsuke, Ishioka Chikashi, Tavtigian Sean V., Hainaut Pierre, Olivier Magali, Impact of mutant p53 functional properties onTP53mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database, 10.1002/humu.20495
  28. Verhoest Grégory, Patard Jean-Jacques, Fergelot Patricia, Jouan Florence, Zerrouki Salim, Dreano Stéphane, Mottier Stéphanie, Rioux-Leclercq Nathalie, Denis Marc G., Paraffin-embedded tissue is less accurate than frozen section analysis for determining VHL mutational status in sporadic renal cell carcinoma, 10.1016/j.urolonc.2010.07.005
  29. Iwata I., Nagafuchi S., Nakashima H., Kondo S., Koga T., Yokogawa Y., Akashi T., Shibuya T., Umeno Y., Okeda T., Shibata S., Kono S., Yasunami M., Ohkubo H., Niho Y., Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese, 10.2337/diabetes.48.2.416
  30. GM Lord, Am J Kidney Dis, 43, 11 (2004)
  31. Feldmeyer N., Schmeiser H.H., Muehlbauer K.-R., Belharazem D., Knyazev Y., Nedelko T., Hollstein M., Further studies with a cell immortalization assay to investigate the mutation signature of aristolochic acid in human p53 sequences, 10.1016/j.mrgentox.2006.02.017
  32. Nedelko Tatiana, Arlt Volker M., Phillips David H., Hollstein Monica, TP53mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours, 10.1002/ijc.24006
  33. Arlt V. M., Aristolochic acid as a probable human cancer hazard in herbal remedies: a review, 10.1093/mutage/17.4.265
  34. Besaratinia A., Pfeifer G. P., Applications of the human p53 knock-in (Hupki) mouse model for human carcinogen testing, 10.1096/fj.10-157263
  35. Pfeifer Gerd P., Hainaut Pierre, On the origin of G→T transversions in lung cancer, 10.1016/s0027-5107(03)00013-7
  36. Mei Nan, Arlt Volker M., Phillips David H., Heflich Robert H., Chen Tao, DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver, 10.1016/j.mrfmmm.2006.08.004
  37. Chen Chung-Hsin, Dickman Kathleen G., Huang Chao-Yuan, Moriya Masaaki, Shun Chia-Tung, Tai Huai-Ching, Huang Kuo-How, Wang Shuo-Meng, Lee Yuan-Ju, Grollman Arthur P., Pu Yeong-Shiau, Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes : Aristolochic acid-induced upper tract urothelial carcinoma, 10.1002/ijc.28013
  38. T Hranjec, Croat Med J, 46, 116 (2005)